Cannabis Science & Health
Multiple Sclerosis Study Could Push Cannabis Compounds Closer to FDA Approval
MMJ is seeking to scientifically assess and prove the effectiveness of their THC/CBD compounds treating and preventing symptoms associated with multiple sclerosis.
Precise Cannabinoid Dosing and Tackling the Opioid Epidemic
Novel cannabinoid formulation, RAPID, is being tested for the treatment of stress and anxiety relief, cognitive focus, various kinds of pain and, migraines and could help curb opioid use.
Canopy Growth to fund Professorship of Cannabis Science at University of British Columbia
CDN $2.5 million of funding will support research into the potential utility of cannabis in addressing the overdose crisis.
Advancing Cannabinoid Research in Australia
Pioneering researchers are developing cannabinoid formulations to help doctors and patients control their dosing, as well as help researchers better study the drug in clinical trials.
5 Patterns of Cannabis Use Identified
New findings will help to inform government and other public health practitioners and shape current and future cannabis policies.
Solving The Big Green Riddle...
For large scale adoption of cannabis in medical formulations, the quality, consistency, and trust in the raw ingredients are essential. To date, no one has been able to solve this all-important riddle...Until now.
Does Cannabis Cure Cancer? We Asked an Expert
Astounding testimonials about cannabis and its derived products shrinking tumours or curing terminal cases are easy to find on the internet. But, what does the science say?
Cannabics Bolsters Team to Develop Cannabinoid Treatments for Cancer
New team members will support Cannabics' data-discovery process with the goal of identifying new cannabinoid diagnostic tests and treatments for cancer.
Trends in Medical Cannabis: Epidiolex and the FDA
What does the recent FDA approval recommendation for Epidiolex mean for cannabis medicine? And, what's best, synthetic or natural cannabinoids? You can get answers in this Interview.
